Abstract
The field of synthetic antibodies is an area that should be continually monitored. Pivotal clinical trials are underway with cancer vaccines, and synthetic HIV vaccines are moving into advanced preclinical studies. Cost issues are being addressed in an attempt to make the products affordable in poor countries where these vaccines are urgently needed.
| Original language | English |
|---|---|
| Pages (from-to) | 387-389 |
| Number of pages | 3 |
| Journal | IDrugs |
| Volume | 8 |
| Issue number | 5 |
| State | Published - May 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'American Chemical Society - 229th National Meeting. Carbohydrate vaccines: 13-17 March 2005, San Diego, CA, USA'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver